Transplant Infectious Disease

pneumonia in kidney transplantation
pp. 551-558(8)
Authors: Goto, N.; Oka, S.

Risk factors for
pp. 559-569(11)
Authors: de Boer, M.G.J.; Kroon, F.P.; le Cessie, S.; de Fijter, J.W.; van Dissel, J.T.

pneumonia is rare in renal transplant recipients receiving only one month of prophylaxis
pp. 570-574(5)
Authors: Anand, S.; Samaniego, M.; Kaul, D.R.

Prospective monitoring of BK virus reactivation in renal transplant recipients in North India
pp. 575-583(9)
Authors: Thakur, R.; Arora, S.; Nada, R.; Minz, M.; Joshi, K.

Mammalian target of rapamycin signal inhibitors could play a role in the treatment of BK polyomavirus nephritis in renal allograft recipients
pp. 584-591(8)
Authors: Sánchez Fructuoso, A.I.; Calvo, N.; Perez-Flores, I.; Valero, R.; Rodríguez-Sánchez, B.; García de Viedma, D.; Muñoz, P.; Barrientos, A.

The use of recombinant human activated protein C (drotrecogin alpha) in solid organ transplant recipients: case series and review of the literature
pp. 592-597(6)
Authors: Funk, D.J.; Palma Vargas, J.; Tuttle-Newhall, J.; Moretti, E.W.

Epidemiology and risk factors for late infection in solid organ transplant recipients
pp. 598-607(10)
Authors: Cervera, C.; Fernández-Ruiz, M.; Valledor, A.; Linares, L.; Antón, A.; Ángeles Marcos, M.; Sanclemente, G.; Hoyo, I.; Cofán, F.; Ricart, M.J.; Pérez-Villa, F.; Navasa, M.; Pumarola, T.; Moreno, A.

Incidence and risk factors for infections after liver transplant: single-center experience at the University Hospital Fundación Santa Fe de Bogotá, Colombia
pp. 608-615(8)
Authors: Vera, A.; Contreras, F.; Guevara, F.

Tobramycin pharmacokinetics in patients with cystic fibrosis before and after bilateral lung transplantation
pp. 616-621(6)
Authors: Walsh, K.A.; Davis, G.A.; Hayes, D. Jr; Kuhn, R.J.; Weant, K.A.; Flynn, J.D.

Preemptive versus prophylactic protocol to prevent cytomegalovirus infection after renal transplantation: a meta-analysis and systematic review of randomized controlled trials
pp. 622-632(11)
Authors: Zhang, L.-F.; Wang, Y.-T.; Tian, J.-H.; Yang, K.-H.; Wang, J.-Q.

Prevalence of infection by JC and BK polyomaviruses in kidney transplant recipients and patients with chronic renal disease
pp. 633-637(5)
Authors: Pires, E.P.; Bernardino-Vallinoto, C.V.; Alves, D.M.; Migone, S.R.C.; Machado, L.F.A.; Ishak, M.O.G.; Ishak, R.; Cayres-Vallinoto, I.M.V.; Vallinoto, A.C.R.

Community-acquired carbapenem-resistant
pp. 638-640(3)
Authors: Solak, Y.; Atalay, H.; Turkmen, K.; Biyik, Z.; Genc, N.; Yeksan, M.

Disseminated
pp. 641-645(5)
Authors: Thompson, G.R.; Wickes, B.L.; Herrera, M.L.; Haman, T.C.; Lewis, J.S.; Jorgensen, J.H.

Lethal human herpesvirus-6 encephalitis after cord blood transplant
pp. 646-649(4)
Authors: Forest, F.; Duband, S.; Pillet, S.; Stachowicz, M.-L.; Cornillon, J.; Dumollard, J.-M.; Peoc'h, M.

Quantitation of human herpesvirus-6 (
pp. 650-653(4)
Authors: Kobayashi, D.; Kogawa, K.; Imai, K.; Tanaka, T.; Hiroi, S.; Satoh, H.; Tanaka-Taya, K.; Nonoyama, S.

Low-level tacrolimus-based immunosuppression and polyomavirus
pp. 654-655(2)
Authors: Costa, C.; Cavallo, R.

Acute appendicitis in the immediate perioperative period following renal transplant
pp. 656-657(2)
Authors: Hughes, D.B.; Coppolino, A.; Kapur, S.; Leeser, D.B.

Thank you to our Expert Peer Reviewers for 2011
pp. 658-659(2)